Using the most important financial ratios of Astrazeneca

1) critically evaluate the financial statements individually across the 4-year period and cross-sectionally and identify their main strengths and weaknesses

2) make recommendations for future improvement

Annual Data 2020-12-31 2019-12-31 2018-12-31 2017-12-31 Current Ratio 1.0.1 0.9624 0.859 0.957 0.8027 0.5282 0.5187 0.5528 0.4832 1.2597 1.2025 1.3609 1.07 80.0917 79.8187 77.655 80.779 19.3936 11.9915 15.3327 16.3677 Long-term Debt / Capital Debt/Equity Ratio Gross Margin Operating Margin EBIT Margin EBITDA Margin Pre-Tax Profit Margin Net Profit Margin ..ll 19.3936 11.9915 15.3327 16.3677 31.2244 27.4196 32.3223 29.882 14.7124 6.3484 9.0222 9.9132 1.1.1 12.0074 5.4749 9.7555 13.3586 Asset Turnover 0.3989 0.3973 0.3642 0.3546 Inventory Turnover Ratio .ul 1.3168 1.5412 1.708 1.4227 Receiveable Turnover Ill 3.6037 4.0331 3.8211 4.0602 Days Sales In Receivables 101.2845 90.5016 95.5213 89.8974 20.1049 8.4064 14.597 17.2335 ROE - Return On Equity Return On Tangible Equity ROA - Return On Assets -18.3281 -6.8528 -10.4475 -13.4201 ... 4.7116 1.9991 3.38 4.5269 ROI - Return On Investment 9.4862 4.046 6.528 8.9063 Book Value Per Share 5.9566 5.5619 5.5421 6.5715 E E E E Operating Cash Flow Per Share 0.6865 0.1079 -0.38 -0.2239 Free Cash Flow Per Share 0.7229 0.1527 -0.2959 -0.1761